The Government of India has granted approval in principle to two vaccines against Coronavirus, setting the stage for the deployment of the first phase of mass vaccination in the country. The Subject Matter Expert Committee (SEC) of the Central Organization for the Control of Medicines Standards recommended the granting of …
Read More »
Dr. Vinod Paul, NITI Aayog member and head of the COVID-19 Working group said on Friday that the government will inoculate 30 million people belonging to priority groups in the first phase of its vaccination campaign. In the next 6 to 8 months, front-line workers, especially those working in healthcare …
Read More »
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »
COVID-19 vaccine: The vaccine will first be administered to around one million healthcare workers. New Delhi: The government plans to vaccinate 30 million people in India against the coronavirus in the next six to eight months, starting with frontline workers. A COVID-19 vaccination trial is taking place across the country …
Read More »
Health Minister Harsh Vardhan today reviewed the vaccine trial in Delhi. (Archive) New Delhi: In the first phase, free coronavirus vaccines will be administered to three million people who have been on the front lines in the fight against the highly contagious disease, Health Minister Harsh Vardhan said today. The …
Read More »
A committee of experts from the country’s top drug regulator recommended on Friday that Covishield, the Indian version of the Covid-19 vaccine developed by the University of Oxford and AstraZeneca, should be approved under certain conditions, The Indian Express has learned. The recommendation is hugely significant as it paves the …
Read More »
India will hold a trial on Saturday before the actual vaccination campaign against the coronavirus disease (Covid-19) in an end-to-end exercise in which all steps will be tested in the states and territories of the Union. The activity will take place in all state capitals at at least three session …
Read More »
On Thursday, Prime Minister Narendra Modi called on the country’s people not to let their guard down even after vaccination, while also announcing that efforts to quickly deliver a Covid-19 vaccine made in India to the sections that need it most. they are in the final stages. . In one …
Read More »
A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »